Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-vaccination safety surveillance of Stamaril in Japan
jRCTs031180027Completed
- Sponsor
- Sanofi
- Start
- Oct 2018
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of 17D yellow fever vaccine in yellow fever, sponsored by Sanofi. Primary endpoint: Safety reports after injection of Stamaril and spontaneous safety reports by participants. Started Oct 2018; status: completed.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on jRCTs031180027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180027.